Clinical Trial

Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the effect of the royal jelly on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-01.
Trial Details
NCT Number NCT06917131
Lead Sponsor Universidade Federal Fluminense
Conditions Hypertension, Cardiovascular Diseases (CVD), Inflammation
Enrollment 34 participants
Start Date 2024-09-18
Primary Completion 2026-12-10 (estimated)
Study Completion 2026-12-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-19